Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia

NCT02618109 is registered in ClinicalTrials.gov with University Hospital, Angers as lead sponsor.

NCT NCT02618109
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02618109 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia
Lead sponsor
University Hospital, Angers
Phase
Phase 4
Overall status
Terminated
Start date
January 31, 2016
Completion date
September 30, 2022
Enrollment
119 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

b acute lymphoblastic leukemia, leukemia relapse